229 related articles for article (PubMed ID: 27199124)
1. Sex dimorphisms of crossbridge cycling kinetics in transgenic hypertrophic cardiomyopathy mice.
Birch CL; Behunin SM; Lopez-Pier MA; Danilo C; Lipovka Y; Saripalli C; Granzier H; Konhilas JP
Am J Physiol Heart Circ Physiol; 2016 Jul; 311(1):H125-36. PubMed ID: 27199124
[TBL] [Abstract][Full Text] [Related]
2. Sexually dimorphic myofilament function and cardiac troponin I phosphospecies distribution in hypertrophic cardiomyopathy mice.
McKee LA; Chen H; Regan JA; Behunin SM; Walker JW; Walker JS; Konhilas JP
Arch Biochem Biophys; 2013 Jul; 535(1):39-48. PubMed ID: 23352598
[TBL] [Abstract][Full Text] [Related]
3. Discrete effects of A57G-myosin essential light chain mutation associated with familial hypertrophic cardiomyopathy.
Kazmierczak K; Paulino EC; Huang W; Muthu P; Liang J; Yuan CC; Rojas AI; Hare JM; Szczesna-Cordary D
Am J Physiol Heart Circ Physiol; 2013 Aug; 305(4):H575-89. PubMed ID: 23748425
[TBL] [Abstract][Full Text] [Related]
4. β-Myosin heavy chain variant Val606Met causes very mild hypertrophic cardiomyopathy in mice, but exacerbates HCM phenotypes in mice carrying other HCM mutations.
Blankenburg R; Hackert K; Wurster S; Deenen R; Seidman JG; Seidman CE; Lohse MJ; Schmitt JP
Circ Res; 2014 Jul; 115(2):227-37. PubMed ID: 24829265
[TBL] [Abstract][Full Text] [Related]
5. Blocking cardiac growth in hypertrophic cardiomyopathy induces cardiac dysfunction and decreased survival only in males.
Luckey SW; Mansoori J; Fair K; Antos CL; Olson EN; Leinwand LA
Am J Physiol Heart Circ Physiol; 2007 Feb; 292(2):H838-45. PubMed ID: 17012357
[TBL] [Abstract][Full Text] [Related]
6. A small-molecule inhibitor of sarcomere contractility suppresses hypertrophic cardiomyopathy in mice.
Green EM; Wakimoto H; Anderson RL; Evanchik MJ; Gorham JM; Harrison BC; Henze M; Kawas R; Oslob JD; Rodriguez HM; Song Y; Wan W; Leinwand LA; Spudich JA; McDowell RS; Seidman JG; Seidman CE
Science; 2016 Feb; 351(6273):617-21. PubMed ID: 26912705
[TBL] [Abstract][Full Text] [Related]
7. Impact of familial hypertrophic cardiomyopathy-linked mutations in the NH2 terminus of the RLC on β-myosin cross-bridge mechanics.
Farman GP; Muthu P; Kazmierczak K; Szczesna-Cordary D; Moore JR
J Appl Physiol (1985); 2014 Dec; 117(12):1471-7. PubMed ID: 25324513
[TBL] [Abstract][Full Text] [Related]
8. Fropofol prevents disease progression in mice with hypertrophic cardiomyopathy.
Huang Y; Lu H; Ren X; Li F; Bu W; Liu W; Dailey WP; Saeki H; Gabrielson K; Abraham R; Eckenhoff R; Gao WD
Cardiovasc Res; 2020 May; 116(6):1175-1185. PubMed ID: 31424496
[TBL] [Abstract][Full Text] [Related]
9. Hypercontractile mutant of ventricular myosin essential light chain leads to disruption of sarcomeric structure and function and results in restrictive cardiomyopathy in mice.
Yuan CC; Kazmierczak K; Liang J; Kanashiro-Takeuchi R; Irving TC; Gomes AV; Wang Y; Burghardt TP; Szczesna-Cordary D
Cardiovasc Res; 2017 Aug; 113(10):1124-1136. PubMed ID: 28371863
[TBL] [Abstract][Full Text] [Related]
10. Rat cardiac troponin T mutation (F72L)-mediated impact on thin filament cooperativity is divergently modulated by α- and β-myosin heavy chain isoforms.
Chandra V; Gollapudi SK; Chandra M
Am J Physiol Heart Circ Physiol; 2015 Oct; 309(8):H1260-70. PubMed ID: 26342069
[TBL] [Abstract][Full Text] [Related]
11. Diastolic dysfunction in familial hypertrophic cardiomyopathy transgenic model mice.
Abraham TP; Jones M; Kazmierczak K; Liang HY; Pinheiro AC; Wagg CS; Lopaschuk GD; Szczesna-Cordary D
Cardiovasc Res; 2009 Apr; 82(1):84-92. PubMed ID: 19150977
[TBL] [Abstract][Full Text] [Related]
12. The E22K mutation of myosin RLC that causes familial hypertrophic cardiomyopathy increases calcium sensitivity of force and ATPase in transgenic mice.
Szczesna-Cordary D; Guzman G; Zhao J; Hernandez O; Wei J; Diaz-Perez Z
J Cell Sci; 2005 Aug; 118(Pt 16):3675-83. PubMed ID: 16076902
[TBL] [Abstract][Full Text] [Related]
13. Age-related changes in familial hypertrophic cardiomyopathy phenotype in transgenic mice and humans.
Luo HC; Pozios I; Vakrou S; Sorensen L; Abraham RM; Abraham T
J Huazhong Univ Sci Technolog Med Sci; 2014 Oct; 34(5):634-639. PubMed ID: 25318870
[TBL] [Abstract][Full Text] [Related]
14. Familial hypertrophic cardiomyopathy: functional effects of myosin mutation R723G in cardiomyocytes.
Kraft T; Witjas-Paalberends ER; Boontje NM; Tripathi S; Brandis A; Montag J; Hodgkinson JL; Francino A; Navarro-Lopez F; Brenner B; Stienen GJ; van der Velden J
J Mol Cell Cardiol; 2013 Apr; 57():13-22. PubMed ID: 23318932
[TBL] [Abstract][Full Text] [Related]
15. Mutations in MYH7 reduce the force generating capacity of sarcomeres in human familial hypertrophic cardiomyopathy.
Witjas-Paalberends ER; Piroddi N; Stam K; van Dijk SJ; Oliviera VS; Ferrara C; Scellini B; Hazebroek M; ten Cate FJ; van Slegtenhorst M; dos Remedios C; Niessen HW; Tesi C; Stienen GJ; Heymans S; Michels M; Poggesi C; van der Velden J
Cardiovasc Res; 2013 Aug; 99(3):432-41. PubMed ID: 23674513
[TBL] [Abstract][Full Text] [Related]
16. Microvascular function is selectively impaired in patients with hypertrophic cardiomyopathy and sarcomere myofilament gene mutations.
Olivotto I; Girolami F; Sciagrà R; Ackerman MJ; Sotgia B; Bos JM; Nistri S; Sgalambro A; Grifoni C; Torricelli F; Camici PG; Cecchi F
J Am Coll Cardiol; 2011 Aug; 58(8):839-48. PubMed ID: 21835320
[TBL] [Abstract][Full Text] [Related]
17. Study familial hypertrophic cardiomyopathy using patient-specific induced pluripotent stem cells.
Han L; Li Y; Tchao J; Kaplan AD; Lin B; Li Y; Mich-Basso J; Lis A; Hassan N; London B; Bett GC; Tobita K; Rasmusson RL; Yang L
Cardiovasc Res; 2014 Nov; 104(2):258-69. PubMed ID: 25209314
[TBL] [Abstract][Full Text] [Related]
18. Mechanical and energetic consequences of HCM-causing mutations.
Ferrantini C; Belus A; Piroddi N; Scellini B; Tesi C; Poggesi C
J Cardiovasc Transl Res; 2009 Dec; 2(4):441-51. PubMed ID: 20560002
[TBL] [Abstract][Full Text] [Related]
19. Molecular basis of force-pCa relation in
Yuan CC; Kazmierczak K; Liang J; Ma W; Irving TC; Szczesna-Cordary D
Proc Natl Acad Sci U S A; 2022 Feb; 119(8):. PubMed ID: 35177471
[TBL] [Abstract][Full Text] [Related]
20. Gene-specific increase in the energetic cost of contraction in hypertrophic cardiomyopathy caused by thick filament mutations.
Witjas-Paalberends ER; Güçlü A; Germans T; Knaapen P; Harms HJ; Vermeer AM; Christiaans I; Wilde AA; Dos Remedios C; Lammertsma AA; van Rossum AC; Stienen GJ; van Slegtenhorst M; Schinkel AF; Michels M; Ho CY; Poggesi C; van der Velden J
Cardiovasc Res; 2014 Jul; 103(2):248-57. PubMed ID: 24835277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
